Delays in Diagnosis of Hematological Cancers in Children: An Analysis of Symptom Recognition to Diagnosis Timeline and Contributing Factors at a Tertiary Hospital in Uganda - Scorecard - MDSpire

Delays in Diagnosis of Hematological Cancers in Children: An Analysis of Symptom Recognition to Diagnosis Timeline and Contributing Factors at a Tertiary Hospital in Uganda

  • By

  • Joan Nakabiri

  • Brian Agaba

  • Ronald Naitala

  • Betty Najjuuko

  • Catherine Asiimwe

  • Hellen Alamo

  • Brian Mafabi

  • Marilyn Hockenberry

  • John M. Ssenkusu

  • Victoria Nankabirwa

  • November 12, 2025

  • 0 min

Share

Clinical Scorecard: Delays in Diagnosis of Hematological Cancers in Children: An Analysis of Symptom Recognition to Diagnosis Timeline and Contributing Factors at a Tertiary Hospital in Uganda

At a Glance

CategoryDetail
ConditionHematological cancers in children (specifically lymphomas and leukemias)
Key MechanismsDelays in diagnosis due to patient/caregiver and healthcare system-related factors
Target PopulationChildren aged 0-18 years diagnosed with leukemia or lymphoma
Care SettingPediatric Hematology and Oncology department of Mulago National Referral Hospital, Uganda

Key Highlights

  • Approximately 400,000 children diagnosed with cancer globally each year, with significant mortality in LMICs.
  • Survival rates for childhood cancer are 80% in high-income countries but less than 20% in LMICs.
  • Delays in diagnosis contribute to poor prognoses and high mortality rates.
  • Lymphomas and leukemias account for nearly 60% of childhood cancer cases.
  • Early detection significantly improves survival rates and treatment success.

Guideline-Based Recommendations

Diagnosis

  • Utilize flow cytometry, bone marrow aspirate, and CT scans for diagnosis confirmation.

Management

  • Implement community cancer awareness programs to improve early detection.

Monitoring & Follow-up

  • Regular follow-up on diagnosed cases to ensure timely treatment initiation.

Risks

  • Financial constraints, caregiver knowledge gaps, misdiagnosis, and inadequate health provider expertise.

Patient & Prescribing Data

Children aged 0-18 years with confirmed diagnoses of leukemia or lymphoma.

Timely intervention is crucial for improving survival rates and reducing morbidity.

Clinical Best Practices

  • Encourage early recognition of symptoms by caregivers.
  • Enhance training for healthcare providers on pediatric cancer diagnosis.
  • Improve access to diagnostic tools in lower-level healthcare facilities.

References

Original Source(s)

Related Content